Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
Informing clinicians about therapeutic advances will aid in their incorporation into standard treatment protocols for the appropriate subgroups of patients with AML.
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
Treatment options should be individualized for patients with relapsed/refractory mantle cell lymphoma (MCL). The selection of optimal second-line therapy depends on the age and fitness of the patients as well as the eligibility for transplant. In the absence of standard management, patients with relapsed/refractory MCL, particularly those who are not eligible for transplant, should be referred for participation in prospective clinical trials investigating novel treatment regimens.
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimizing First-Line Therapy for Advanced Stage Classic Hodgkin Lymphoma
Recent studies are demonstrating the utility of novel agents and modifications to existing regimens as viable first-line options in early- and advanced-stage HL. An awareness of the clinical studies evaluating the utility of these treatment modalities will help oncology clinicians determine how to optimally incorporate them into the standard of care for patients and improve patient outcomes.
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Expanding Options for Patients With Acute Myeloid Leukemia: Current and Evolving Therapeutic Approaches
The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with AML.
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation